The NK1 receptor antagonist NKP608 inhibits proliferation of human colorectal cancer cells via Wnt signaling pathway

Abstract Background Neurokinin1 (NK1) receptor has played a vital role in the development of tumor. However, NKP608 as a NK1 receptor antagonist whether has the effect of the resistance of colorectal cancer is still unclear. Thereby, in this study, we investigated the role of NKP608 on human colorec...

Full description

Bibliographic Details
Main Authors: Xiao-Ling Niu, Jian-Feng Hou, Jing-Xiang Li
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Biological Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40659-018-0163-x
_version_ 1828891839834357760
author Xiao-Ling Niu
Jian-Feng Hou
Jing-Xiang Li
author_facet Xiao-Ling Niu
Jian-Feng Hou
Jing-Xiang Li
author_sort Xiao-Ling Niu
collection DOAJ
description Abstract Background Neurokinin1 (NK1) receptor has played a vital role in the development of tumor. However, NKP608 as a NK1 receptor antagonist whether has the effect of the resistance of colorectal cancer is still unclear. Thereby, in this study, we investigated the role of NKP608 on human colorectal cancer and explored the underlying mechanism. Methods The cell proliferation of colorectal cancer cells was detected by cell counting kit-8 (CCK8) assay, cell migration and invasion were assessed by transwell assay, the apoptotic ratio of cells was assessed by Annexin V-fluorescein isothiocyanate/propidium iodide stained and flow cytometry. The involvement of molecular mechanisms was examined by western blot. Results In this study, we found that NKP608 inhibited the proliferation, migration/invasion of HCT116 cells. In addition, NKP608 reduced expressions of Wnt-3a, β-catenin, Cyclin D1, and (vascular endothelial growth factor) VEGF while induced expression of E-Cadherin. Furthermore, flow cytometry analyzed that NKP608 induced apoptosis of HCT116 cells, consistently, western blotting detecting of apoptosis-related proteins revealed that NKP608 downregulated Bcl-2 while upregulated Bax and Active-Caspase-3. Conclusions Taken together, our results demonstrated that NKP608 inhibited colorectal cancer cell proliferation, migration and invasion via suppressing the Wnt/β-catenin signaling pathway. Therefore, NKP608 might represent a promising therapeutic agent in the treatment of colorectal cancer.
first_indexed 2024-12-13T13:25:11Z
format Article
id doaj.art-81b2cc1377e4425e804c50983221ccd2
institution Directory Open Access Journal
issn 0717-6287
language English
last_indexed 2024-12-13T13:25:11Z
publishDate 2018-05-01
publisher BMC
record_format Article
series Biological Research
spelling doaj.art-81b2cc1377e4425e804c50983221ccd22022-12-21T23:44:19ZengBMCBiological Research0717-62872018-05-015111810.1186/s40659-018-0163-xThe NK1 receptor antagonist NKP608 inhibits proliferation of human colorectal cancer cells via Wnt signaling pathwayXiao-Ling Niu0Jian-Feng Hou1Jing-Xiang Li2Department of Traditional Chinese Medicine, Shanghai Pudong New Area Zhoupu HospitalDepartment of Hepatobiliary Surgery, The First Hospital of Yulin CityAnorectal Department, Dongzhimen Hospital, Beijing University of Chinese MedicineAbstract Background Neurokinin1 (NK1) receptor has played a vital role in the development of tumor. However, NKP608 as a NK1 receptor antagonist whether has the effect of the resistance of colorectal cancer is still unclear. Thereby, in this study, we investigated the role of NKP608 on human colorectal cancer and explored the underlying mechanism. Methods The cell proliferation of colorectal cancer cells was detected by cell counting kit-8 (CCK8) assay, cell migration and invasion were assessed by transwell assay, the apoptotic ratio of cells was assessed by Annexin V-fluorescein isothiocyanate/propidium iodide stained and flow cytometry. The involvement of molecular mechanisms was examined by western blot. Results In this study, we found that NKP608 inhibited the proliferation, migration/invasion of HCT116 cells. In addition, NKP608 reduced expressions of Wnt-3a, β-catenin, Cyclin D1, and (vascular endothelial growth factor) VEGF while induced expression of E-Cadherin. Furthermore, flow cytometry analyzed that NKP608 induced apoptosis of HCT116 cells, consistently, western blotting detecting of apoptosis-related proteins revealed that NKP608 downregulated Bcl-2 while upregulated Bax and Active-Caspase-3. Conclusions Taken together, our results demonstrated that NKP608 inhibited colorectal cancer cell proliferation, migration and invasion via suppressing the Wnt/β-catenin signaling pathway. Therefore, NKP608 might represent a promising therapeutic agent in the treatment of colorectal cancer.http://link.springer.com/article/10.1186/s40659-018-0163-xNKP608Colorectal cancerWnt signaling pathwayProliferation
spellingShingle Xiao-Ling Niu
Jian-Feng Hou
Jing-Xiang Li
The NK1 receptor antagonist NKP608 inhibits proliferation of human colorectal cancer cells via Wnt signaling pathway
Biological Research
NKP608
Colorectal cancer
Wnt signaling pathway
Proliferation
title The NK1 receptor antagonist NKP608 inhibits proliferation of human colorectal cancer cells via Wnt signaling pathway
title_full The NK1 receptor antagonist NKP608 inhibits proliferation of human colorectal cancer cells via Wnt signaling pathway
title_fullStr The NK1 receptor antagonist NKP608 inhibits proliferation of human colorectal cancer cells via Wnt signaling pathway
title_full_unstemmed The NK1 receptor antagonist NKP608 inhibits proliferation of human colorectal cancer cells via Wnt signaling pathway
title_short The NK1 receptor antagonist NKP608 inhibits proliferation of human colorectal cancer cells via Wnt signaling pathway
title_sort nk1 receptor antagonist nkp608 inhibits proliferation of human colorectal cancer cells via wnt signaling pathway
topic NKP608
Colorectal cancer
Wnt signaling pathway
Proliferation
url http://link.springer.com/article/10.1186/s40659-018-0163-x
work_keys_str_mv AT xiaolingniu thenk1receptorantagonistnkp608inhibitsproliferationofhumancolorectalcancercellsviawntsignalingpathway
AT jianfenghou thenk1receptorantagonistnkp608inhibitsproliferationofhumancolorectalcancercellsviawntsignalingpathway
AT jingxiangli thenk1receptorantagonistnkp608inhibitsproliferationofhumancolorectalcancercellsviawntsignalingpathway
AT xiaolingniu nk1receptorantagonistnkp608inhibitsproliferationofhumancolorectalcancercellsviawntsignalingpathway
AT jianfenghou nk1receptorantagonistnkp608inhibitsproliferationofhumancolorectalcancercellsviawntsignalingpathway
AT jingxiangli nk1receptorantagonistnkp608inhibitsproliferationofhumancolorectalcancercellsviawntsignalingpathway